🔴 Solid Biosciences is trading 5% down with no confirmed catalyst

Solid Biosciences is trading at $6.90, down 5.22%, with no confirmed reason for the decline. The company’s investor-relations page lists no release dated September 29, 2026. Broader market context shows modest index declines, but does not establish a direct cause for the stock’s move lower.